You are here: Industry Insights > CAR T

News List

Pfizer, Allogene link to develop cancer therapies pharmatimes
July 18, 2018
Pfizer and Allogene have entered into an agreement to develop allogeneic CAR T cell therapies.
Pfizer and Allogene Therapeutics enter into asset contribution agreement for Pfizer's allogeneic CAR T immuno-oncology portfolio worldpharmanews
April 09, 2018
Pfizer Inc today announced that the two companies have entered into an asset contribution agreement for Pfizer's portfolio of assets related to allogeneic chimeric antigen receptor T cell (CAR T) therapy
Proposed guidelines for handling CAR T cell side effects europeanpharmaceuticalreview
September 21, 2017
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge for oncologists…
Takeda partners up to develop "next generation" CAR T solid tumour therapy pharmafile
September 05, 2017
Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR T) therapy for effectively treating solid tumours, it has emerged.
FDA approves CAR T cell therapy for children with leukaemia europeanpharmaceuticalreview
September 01, 2017
The FDA has approved CAR T cell therapy for treatment of children with acute lymphoblastic leukemia…
FDA approves CAR T cell therapy for kids with leukemia biospectrumasia
September 01, 2017
St. Baldrick's Foundation plays a key role in bringing this therapy to reality.
New research claims first response of nervous system tumour to CAR T therapy pharmafile
August 30, 2017
Researchers at a General Hospital in Massachusetts has claimed first-ever response of a nervous system tumour to CAR T cancer therapy.

Previous page 1 2 Next page